Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
62.73
+1.28 (2.08%)
Jun 27, 2025, 4:00 PM - Market closed
Rhythm Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 12 professional analysts, the 12-month price target for Rhythm Pharmaceuticals stock ranges from a low of $65 to a high of $94. The average analyst price target of $77.5 forecasts a 23.55% increase in the stock price over the next year.
Price Target: $77.50 (+23.55%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Rhythm Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 8 | 8 | 8 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $84 | Buy | Reiterates | $84 | +33.91% | Jun 26, 2025 |
| Stifel | Stifel | Strong Buy Maintains $78 → $94 | Strong Buy | Maintains | $78 → $94 | +49.85% | May 29, 2025 |
| Needham | Needham | Strong Buy Maintains $66 → $72 | Strong Buy | Maintains | $66 → $72 | +14.78% | May 7, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $63 → $68 | Strong Buy | Maintains | $63 → $68 | +8.40% | Apr 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 → $80 | Strong Buy | Reiterates | $70 → $80 | +27.53% | Apr 8, 2025 |
Financial Forecast
Revenue This Year
179.00M
from 130.13M
Increased by 37.56%
Revenue Next Year
313.24M
from 179.00M
Increased by 74.99%
EPS This Year
-2.76
from -4.34
EPS Next Year
-1.45
from -2.76
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 191.5M | 420.0M | 686.8M | ||
| Avg | 179.0M | 313.2M | 563.2M | ||
| Low | 166.6M | 226.8M | 420.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.1% | 134.6% | 119.3% | ||
| Avg | 37.6% | 75.0% | 79.8% | ||
| Low | 28.0% | 26.7% | 34.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.44 | -0.23 | 3.16 | ||
| Avg | -2.76 | -1.45 | 1.86 | ||
| Low | -3.18 | -2.50 | 0.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.